Aratana Therapeutics Inc (NASDAQ:PETX)

19.78
Delayed Data
As of 9:53am ET
 +0.13 / +0.66%
Today’s Change
9.20
Today|||52-Week Range
22.54
+11.00%
Year-to-Date

Today’s Trading

Previous close19.65
Today’s open19.63
Day’s range18.55 - 19.80
Volume12,605
Average volume (3 months)280,882
Market cap$682.0M
Dividend yield--
Data as of 9:53am ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)+61.39%
Earnings growth (this year)-251.92%
Earnings growth (next 5 years)-32.79%
Revenue growth (last year)--
P/E ratio197.8
Price/Sales1,717.35
Price/Book5.35

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.42-1.95%
ENTAEnanta Pharmaceutica...+0.41+1.16%
SCMPSucampo Pharmaceutic...+0.45+3.04%
TGTXTG Therapeutics Inc+1.30+8.75%
Data as of 10:08am ET, 03/05/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$123.0K
Annual profit (last year)-$4.3M
Net profit margin-3,485.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Financial Officer &
Treasurer
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account